[{"symbol": "VRTX", "publishedDate": "2019-03-31 10:01:36", "title": "Biotech Stocks to Buy Right Now", "image": "https://cdn.snapi.dev/images/v1/u/r/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5176442fscientist-holding-a-test-tube.jpg", "site": "The Motley Fool", "text": "These biotech stocks could have a lot of room to run.", "url": "https://www.fool.com/investing/2019/03/31/3-top-biotech-stocks-to-buy-right-now.aspx?source=iedfolrf0000001"}, {"symbol": "VRTX", "publishedDate": "2019-03-29 13:30:17", "title": "Celgene and Vertex Pharmaceuticals ?", "image": "https://cdn.snapi.dev/images/v1/b/i/biotech26.jpg", "site": "Zacks Investment Research", "text": "Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Celgene and Vertex Pharmaceuticals. But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look.", "url": "https://www.zacks.com/stock/news/366969/celg-or-vrtx-which-is-the-better-value-stock-right-now"}, {"symbol": "VRTX", "publishedDate": "2019-03-25 13:38:46", "title": "Why Vertex's Grip On This Huge Sales Opportunity Now Looks Unbreakable", "image": "https://cdn.snapi.dev/images/v1/v/e/vert2.jpg", "site": "Investors Business Daily", "text": "A tiny biotech called Proteostasis won't be able to rival Vertex in cystic fibrosis treatment, analysts said Monday. Proteostasis' triple-medicine missed the bar set by Vertex's.", "url": "https://feedproxy.google.com/~r/InternetTechnologyRss/~3/ve8cj1MX_Sc/"}, {"symbol": "VRTX", "publishedDate": "2019-03-24 09:00:00", "title": "Better Buy:  Vertex Pharmaceuticals vs.  Regeneron Pharmaceuticals", "image": "https://cdn.snapi.dev/images/v1/p/h/pharma12.jpg", "site": "The Motley Fool", "text": "Which stock wins in a battle between these two successful biotechs?", "url": "https://www.fool.com/investing/2019/03/24/better-buy-vertex-pharmaceuticals-vs-regeneron-pha.aspx?source=iedfolrf0000001"}, {"symbol": "VRTX", "publishedDate": "2019-03-19 16:03:00", "title": "Biotech Giant Tumbles On Downgrade Amid Payer Pushback In Europe", "image": "https://cdn.snapi.dev/images/v1/v/e/vertex-2.jpg", "site": "Investors Business Daily", "text": "Vertex Pharmaceuticals stock slipped below its 50-day moving average Tuesday after sustaining a downgrade and price target cut on European opposition to its cystic fibrosis treatments.", "url": "https://feedproxy.google.com/~r/BusinessRss/~3/OEouwjf0CbI/"}, {"symbol": "VRTX", "publishedDate": "2019-03-10 19:30:00", "title": "Why Vertex's Dilemma Makes It the Best Biotech Stock to Buy Now", "image": "https://cdn.snapi.dev/images/v1/v/e/vertex-1.jpg", "site": "The Motley Fool", "text": "Excellent clinical trial results are giving Vertex a problem most biotechs wish they had.", "url": "https://www.fool.com/investing/2019/03/10/does-vertexs-dilemma-make-it-the-best-biotech-stoc.aspx?source=iedfolrf0000001"}, {"symbol": "VRTX", "publishedDate": "2019-03-10 09:25:28", "title": "Stocks This Week: Short Vertex Pharmaceuticals", "image": "https://cdn.snapi.dev/images/v1/v/e/vertex.jpg", "site": "Forbes", "text": "Vertex Pharmaceuticals is picked up by the cycle scan. The weekly price cycle gives a sell signal on March 13th.", "url": "https://www.forbes.com/sites/greatspeculations/2019/03/10/stocks-this-week-buy-micron-and-short-vertex-pharmaceuticals/#2215d11437d4"}, {"symbol": "VRTX", "publishedDate": "2019-02-05 19:00:00", "title": "MARKET UPDATE: Vertex Pharmaceuticals Incorporated", "image": "https://cdn.snapi.dev/images/v1/p/l/plw-cuhdlfwv-3.jpg", "site": "Investors Business Daily", "text": "Investor's Business Daily's MARKET UPDATE with Alissa Coram and Ken Shreve.", "url": "https://www.youtube.com/watch?v=PLW-cUHDLfw&t=291s"}, {"symbol": "VRTX", "publishedDate": "2019-01-09 19:00:00", "title": "Indexes Open Lower; Retailers Slump On Holiday Sales", "image": "https://cdn.snapi.dev/images/v1/s/-/s-dycwio8y4.jpg", "site": "Investors Business Daily", "text": "Alissa Coram & Ken Shreve\u00b4s market update", "url": "https://www.youtube.com/watch?v=s-DycwiO8Y4"}]